Barclays
BMRA icon

Barclays’s Biomerica BMRA Stock Holding History

Barclays’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-9
Closed – – 4871
2021
Q1 		$0 Sell
9
-2,991
-100% -$153K ﹤0.01% 4707
2020
Q4 		$120K Sell
3,000
-1,825
-38% -$91.4K ﹤0.01% 4051
2020
Q3 		$267K Sell
4,825
-1,438
-23% -$93K ﹤0.01% 3668
2020
Q2 		$363K Buy
+6,263
New +$351K ﹤0.01% 3598
2018
Q4 		– Sell
-7
Closed – – 6943
2018
Q3 		$0 Buy
+7
New +$210 ﹤0.01% 7122

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FC
Fore Capital New York $338M AUM 10.07% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HIMC
Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Barclays's BMRA Position: Q2 2021 in Review

Barclays sold out of Biomerica (BMRA) in Q2 2021, closing a stake of 9 shares.

Barclays first reported a position in BMRA in Q3 2018 and held it in 5 quarters. The position peaked at $363K in Q2 2020. 26 funds tracked by Wall St. Rank hold BMRA as of Q2 2021.

  • Barclays reported no remaining Biomerica position as of Q2 2021 after selling out during the quarter.
  • Barclays sold 9 Biomerica shares in Q2 2021.
  • Barclays first reported a position in Biomerica in Q3 2018 and held it in 5 quarters.
  • Barclays's Biomerica position peaked at $363K in Q2 2020.
  • 26 funds tracked by Wall St. Rank held Biomerica as of Q2 2021.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.